NanoVibronix, Inc. Common Stock
Symbol: NAOV (NASDAQ)
Company Description:
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.
- Today's Open: $5.709
- Today's High: $5.709
- Today's Low: $5.605
- Today's Volume: 49
- Yesterday Close: $5.64
- Yesterday High: $5.805
- Yesterday Low: $5.53
- Yesterday Volume: 59.13K
- Last Min Volume: 3
- Last Min High: $5.605
- Last Min Low: $5.605
- Last Min VWAP: $5.605
- Name: NanoVibronix, Inc. Common Stock
- Website: https://www.nanovibronix.com
- Listed Date: 2015-04-24
- Location: TYLER, TX
- Market Status: Active
- CIK Number: 0001326706
- SIC Code: 3842
- SIC description: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
- Market Cap: $4.91M
- Round Lot: 100
- Outstanding Shares: 871.10K
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-17 | 8-K | View |
2025-09-17 | 424B5 | View |
2025-09-15 | S-3 | View |
2025-08-19 | 10-Q | View |
2025-08-14 | 8-K | View |
2025-08-14 | NT 10-Q | View |
2025-08-08 | 8-K | View |
2025-07-30 | 8-K | View |
2025-07-22 | 8-K | View |
2025-07-18 | 8-K | View |
2025-07-11 | 8-K | View |
2025-07-09 | 8-K | View |
2025-06-25 | DEFA14A | View |
2025-06-20 | DEF 14A | View |
2025-06-09 | PRE 14A | View |
2025-06-04 | 8-K | View |
2025-05-20 | 10-Q | View |
2025-05-19 | SCHEDULE 13G | View |
2025-05-16 | 8-K | View |
2025-05-16 | 424B4 | View |